IGXT ($0.93) IGXT is actually holding pretty well (again considering brutal market). Waiting for market correction here.
Reminded notes: Expecting news soon. Perhaps 1st week of May. Recall: IntelGenx Submit Response to FDA CRL for RHB-103 Migraine Oral-FilmGlobeNewswire(Mon, Mar 3).
I am trying to time this...Mar 3rd was the PR release of Submit..now it's April 2 (almost a month past now..we should be expecting FDA any day now..then PR from company.)